Efficacy and safety of surufatinib plus PD-1/PD-L1 inhibitors as first-line maintenance therapy in extensive-stage small cell lung cancer.

Bibliographic Details
Published in:	Holistic Integrative Oncology Vol. 5; no. 1; pp. 1 - 11
Main Authors:	Tao, Haitao, Chen, Jianhua, Lv, Dongqing, Wang, Jinliang, Ma, Junxun, Yi, Tienan, Wu, Shikai, Zhou, Xiangdong, Zhang, Xingxing, Chen, Dongmei, Fan, Songhua, Zhong, Chen, Guan, Chunyu, Shi, Michael, Su, Weiguo, Hu, Yi
Format:	research tables/charts Journal Article
Published:	Springer Nature 7/28/2026
Online Access:	View this record in EBSCOhost

Internet